Table 1: Indications for invasive coronary angiography. |
|
ACS- STEMI |
Angiography and primary angioplasty are recommended over fibrinolysis in patients with < 12 hours of onset of symptoms or in > 12 hours, after fibrinolysis, if symptoms persist, or there are hemodynamic instability or severe arrhythmias |
ACS- NSTEMI |
Urgent angiography (< 2 h) is indicated in very high-risk patients. Within 24 hours at high risk: persistent angina, ECG changes or enzyme elevation. In 12-48 h if symptoms persist, or there are severe ischemia or LV dysfunction |
CCS |
Persistence of symptoms after optimal medical treatment. Severe ischemia unveiled with non-invasive studies, or inconclusive results with a high probability of the disease. Significant high-risk lesions on coronary CT angiography |
Direct |
Before high-risk heart surgery, or organ transplantation. Prior to surgery for aneurysm or aortic dissection. Hypertrophic cardiomyopathy with angina or Kawasaki disease with documented coronary aneurysms |
Indications for invasive coronary angiography: ACS-STEMI = ST segment elevation acute coronary syndrome; ACS-NSTEMI = non-ST segment elevation acute coronary syndrome; CCS = chronic coronary syndrome; EKG = electrocardiogram; LV = left ventricular.7-9 |